Allergy treatment Market Expected to reach US$ 41,171.7 Mn in 2025: Asia Pacific to be the most lucrative region by 2025

Allergy is the damaging immune reaction produced by the body to a specific allergen or substance such as pollen, dust, mite, food etc. the treatment for allergy includes anti-allergy drugs and immunotherapy, which reduces the response of allergen responsible for allergy b decreasing the sensitivity of substance. The global Allergy Treatment Market was valued at US$ 25,500.0 Mn in 2016 and is estimated to reach US$ 41,171.7 Mn by 2025 at a CAGR of 5.5% from 2017 to 2025.

The advances in treatment for various type of allergy, and rising prevalence of allergic conditions is expected to drive the growth of allergy treatment market over the forecast period. Immunotherapy is the most prominent treatment for various allergic diseases, and act by curing the root cause of allergy. Immunotherapy is effective in controlling the clinical symptoms, preventing the worsening of a disease, reducing or eliminating the need for medication, and reducing the degree of specific and nonspecific bronchial hyperactivity. Immunotherapy is available in two types: subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). The rising adoption of immunotherapy in developed as well as developing countries owing to its positive response is expected to drive the growth of the allergy treatment market.

Inquire for a Sample Copy of Report – http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11357

The global allergy treatment market has been segmented on the basis of allergy type, treatment, and distribution channel. The allergy type segment is further segmented as, food allergy, inhaled allergy, drug allergy, and others including allergy conjunctivitis, skin allergy etc. The inhaled allergy segment dominated the global allergy treatment market in 2016. Inhaled allergy is also known as respiratory allergy. Allergic asthma, allergic rhinitis are the most common type of inhaled allergy. Allergic rhinitis affects most population all over the world. According to the World Allergy Organization (WAO), about 500 million people worldwide are affected by allergic rhinitis, in 2015. Changing climate with increased pollution, CO2 levels, and particulate matter (PM), around the world is pushing the prevalence and intensity of allergies. The rising prevalence of allergies is expected to grow the allergy treatment market by allergy type. In 2015, the prevalence of allergic diseases globally was estimated to be 20% to 30% of the world’s population, which is about 1 billion people, suffering from some kind of allergies.

On the basis of treatment, the global allergy treatment market is segmented as anti-allergy drugs and immunotherapy. Anti-allergy segment is further segmented as antihistamines, corticosteroids, leukotriene inhibitors, and others includes mast cell stabilizers, Nasal anticholinergic, Decongestants etc. Antihistamines accounted major share in 2016 and expected to register high CAGR over the forecast period. The immunotherapy segment is further segmented as Subcutaneous Immunotherapy (SCIT), and Sublingual Immunotherapy (SLIT). Rising prevalence of allergic conditions and increasing demand for safer and effective treatment are expected to boost the growth of the immunotherapy segment during the forecast period. The subcutaneous immunotherapy accounted major share in 2016 and expected to register high CAGR over the forecast period.

By distribution channel, the global allergy treatment market is segmented as hospital pharmacies, retail pharmacies & drug stores, and online pharmacies. The retail pharmacies & drug stores segment is accounted major share in 2016 and expected to generate high CAGR over the forecast period. The factor such as easy availability of allergy drugs on retail pharmacies & drug stores and some drugs do not require prescription for allergies such as itching and runny nose, are expected to drive growth of segment over the forecast period. The online pharmacy is the new trend in the pharmaceutical industry owing to its advantages such as home delivery services and discount on medicines. These factors are likely to drive the segment growth during the forecast period.

The global Allergy treatment market has been segmented into five key regions, namely, North America, Europe, Asia Pacific, Latin America and the Middle East & Africa, which are further categorized into various countries under each region. North America dominated the global allergy treatment market in 2016 owing to factors such as fast growing life science industry, rising focus on research & new drug development, and increasing number of pharmaceutical companies focusing on immunotherapy are driving demand for allergy treatment in North America. Europe was the second largest regional market for allergy treatment in 2016 and dominated allergy immunotherapy in 2016. Most of the immunotherapy drugs are approved in Europe and the adoption of the therapy is rising with high pace over the forecast period. Asia Pacific is projected to be the most lucrative market for global allergy treatment market and is expected to expand at the highest growth rate from 2017 to 2025., and rise in government initiatives, grants, funds, increase in life science R&D spending, especially in India, China and Japan and dedicated research commercial zones are attracting domestic and foreign players to invest and enter the lucrative research sector in Asia Pacific.

ALK dominated the global allergy treatment market by immunotherapy and GlaxoSmithKline plc dominated by anti-allergic drugs market 2016. Major factors attributed to its dominance are broad product portfolio and widespread market presence. Stallergenes Greer secured the second market position in 2016. Other players in the global allergy treatment market includes Allergy Therapeutics, Meda Pharmaceuticals Inc., Sunovion Pharmaceuticals Inc., Allergan, Allergon AB, HAL Allergy Group, and Teva Pharmaceutical among other local and regional players.

Read Report with Complete TOC – http://www.transparencymarketresearch.com/allergy-treatment-market.html

Name: Rohit Bhisey
Organization: Transparency Market Research

ReleaseID: 8172